Skip to main content

Advertisement

Log in

No evidence of lymphatic filariasis transmission in Bamako urban setting after three mass drug administration rounds

  • Research
  • Published:
Parasitology Research Aims and scope Submit manuscript

A Correction to this article was published on 10 November 2022

This article has been updated

Abstract

Lymphatic filariasis (LF) elimination activities started in Mali in 2005 in the most endemic areas and reached countrywide coverage in 2009. In 2004, the district of Bamako was endemic for LF with a prevalence of 1.5%. The current study was designed to determine LF endemicity level in the urban area of Bamako after three rounds of ivermectin and albendazole mass drug administration (MDA). A cross-sectional study was conducted in 2011 in Bamako city, consisting of human prevalence and entomological surveys. Volunteers aged 14 years and above were invited to participate and tested for evidence of Wuchereria bancrofti using night time blood thick smear microfilarial count and blood spots for LF antibodies using the SD BIOLINE Oncho/LF IgG4 Biplex rapid test (Ov16/Wb123). Mosquitoes were collected using CDC light and gravid traps and tested using molecular methods. Poolscreen software v2.0 was used to estimate vector transmission potential. Of the 899 volunteers, one (0.11%) was found to be positive for LF using the Oncho/LF IgG4 Biplex rapid test, and none was found to have Wuchereria bancrofti microfilariae. No mosquitoes were found infected among 6174 Culex spp. (85.2%), 16 Anopheles gambiae s.l. (An. gambiae s.l.) (0.2%), 26 Aedes spp. (0.4%), 858 Ceratopogonidae (11.8%) and 170 other insects not identified (2.3%) tested. Our data indicate that there was no active LF transmission in the low prevalence urban district of Bamako after three MDA rounds. These data helped the National LF programme move forward towards the elimination goal.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data availability

The data that support the findings of this study are available from the corresponding author (Moussa Sangare, mbsangare@icermali.org), upon reasonable request.

Change history

Abbreviations

CDC:

United States Center for Disease Control and Prevention

DNA:

Deoxyribonucleic acid

GPELF:

The Global Programme to Eliminate Lymphatic Filariasis

ICT:

Immunochromatographic test

LF:

Lymphatic filariasis

MDA:

Mass drug administration

PCR:

Polymerase chain reaction

References

Download references

Acknowledgements

The author would like to express warm gratitude to the many people who gave generously of their time and knowledge in the preparation and the implementation of this study. Especially, the health staff of Bamako district, the community health workers and all the participants.

Funding

This study was supported in part by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (USA), and the University of Science, Techniques and Technologies of Bamako, Bamako, Mali.

Author information

Authors and Affiliations

Authors

Contributions

Yaya Ibrahim Coulibaly, Moussa Sangare, Housseini Dolo, Moses John Bockarie, Benjamin G. Koudou, Louise A. Kelly-Hope, Amy D. Klion and Thomas B. Nutman designed and conceived the study.

Amy D. Klion, Louise A. Kelly-Hope, Moses John Bockarie and Thomas B. Nutman approved final version of the manuscript and helped with the analysis.

Yaya Ibrahim Coulibaly, Moussa Sangare, Housseini Dolo, Siaka Yamoussa Coulibaly, Ilo Dicko, Lamine Diarra, Abdoul Fatao Diabaté, Lamine Soumaoro, Michel Emmanuel Coulibaly, Salif Seriba Doumbia and Abdallah Amadou Diallo collected, processed the samples and drafted the manuscript.

Yaya Ibrahim Coulibaly, Moussa Sangare, Housseini Dolo, Benjamin G. Koudou, Amy D. Klion, Louise A. Kelly-Hope, Thomas B. Nutman and Moses John Bockarie managed the data, did the statistical analysis and helped to draft the manuscript. All the authors read and approved the final manuscript.

Corresponding author

Correspondence to Moussa Sangare.

Ethics declarations

Ethics approval

A collective quartier-wide oral consent was obtained from village elders and head of quartiers, and all mosquito collectors and participants enrolled in parasitological study signed an individual written consent. The study protocol and consent forms were approved by the Malian National Institute of Research in Public Health Ethical Committee, Bamako, Mali (Reference #9/11/CE-INRSP).

Consent to participate

Informed consent was obtained from all individual participants included in the study.

Competing interests

The authors declare no competing interests.

Additional information

Handling Editor: Una Ryan

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The original online version of this article was revised due to a retrospective Open Access cancellation.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Coulibaly, Y.I., Sangare, M., Dolo, H. et al. No evidence of lymphatic filariasis transmission in Bamako urban setting after three mass drug administration rounds. Parasitol Res 121, 3243–3248 (2022). https://doi.org/10.1007/s00436-022-07648-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00436-022-07648-8

Keywords

Navigation